Test Price
2,800 AED✅ Home Collection Available
FGA Gene Congenital Afibrinogenemia Genetic Test in UAE
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% diagnostic sensitivity for FGA pathogenic variants via ISO‑accredited NGS with confirmatory Sanger backup.
- Premium Logistics: Paid hospital‑grade home collection using ISO‑certified cold‑chain transport and VIP mobile phlebotomy – a seamless, safe experience.
- Clinical Guidance: Complimentary, DHA‑licensed telephonic post‑test clinical correlation session to explain results and next steps.
- Insurance: Direct billing verification; send your Emirates ID and policy via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
This Next‑Generation Sequencing (NGS) test screens the entire FGA gene for mutations causing congenital afibrinogenemia, the complete absence of fibrinogen – a life‑long bleeding disorder inherited in an autosomal recessive pattern. In the UAE, early molecular confirmation allows targeted fibrinogen replacement, differentiation from other coagulopathies, and informed family planning.
| Feature | Our FGA NGS Test | Traditional Coagulation Panel |
|---|---|---|
| Diagnostic Target | Direct detection of FGA pathogenic variants | Functional fibrinogen activity (Clauss method) |
| Sensitivity | >99.9% for point mutations, small indels, CNVs | Cannot identify carrier status or genetic subtype |
| Turnaround | 3–4 weeks | Same day–24 hours |
| Clinical Utility | Definitive diagnosis, prenatal carrier screening, personalized management | Initial screening; cannot confirm genetic aetiology |
Physician Insight & Safety Protocols
“As a DHA‑licensed Consultant Medical Geneticist, I emphasize that a positive FGA genetic result must be interpreted alongside your personal bleeding history and family pedigree. No single laboratory parameter can replace a thorough clinical evaluation. Please maintain all prescribed treatments and discuss any test findings with your treating physician before making any changes.” – Lina Osama Zaki Quteineh, DHA 9294403
Safety Advisory
Do not discontinue or adjust any prescribed anticoagulant, antiplatelet, or fibrinogen concentrate therapy without consulting your doctor. Abruptly stopping medications can trigger life‑threatening bleeding or clotting events.
Exclusion Criteria & Emergency Red Flags
- Home collection refusal: Severe needle phobia with no venous access, active skin infection at puncture site, or inability to apply pressure post‑draw.
- Patient unsuitable for phlebotomy due to: Platelet count <20 × 109/L, known allergy to lidocaine in local anaesthetic, or recent major trauma within 72 hours.
- Immediate emergency care (ER) if you experience: Sudden, profuse bleeding from any site, uncontrolled epistaxis lasting >15 minutes, haemoptysis, melena, or sudden severe headache – do not wait for genetic test results.
Patient FAQ & Clinical Guidance
1. What is the FGA gene congenital afibrinogenemia NGS test?
This sequences the entire FGA gene to identify pathogenic mutations that cause a complete lack of fibrinogen from birth.
2. What sample is required and how is the collection performed?
A single blood draw is collected by a DHA‑licensed phlebotomist at your home using VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection. Sample collection is available daily from 8 AM to 11 PM.
3. What does a positive result mean and what are the next steps?
A positive result indicates you carry two disease‑causing FGA variants, confirming congenital afibrinogenemia; you should immediately consult a haematologist for fibrinogen replacement therapy and genetic counselling.
UAE Regulatory & Data Privacy Adherence
This laboratory operates under DHA License No. 1143 (Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE) and is certified ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139). All genetic data is processed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Testing on individuals under 18 requires explicit parental consent. Always consult a qualified healthcare professional for interpretation.
Clinical & Logistical Metadata
| Test Name | FGA Gene Congenital Afibrinogenemia Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral whole blood (EDTA) – VIP Mobile Phlebotomy available |
| Methodology Used | Next‑Generation Sequencing (NGS) with Sanger confirmatory sequencing |
| ICD-10-CM Code | D68.2 |
| LOINC Code | 82174-8 |
| DHA Facility License & Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians